Urinary tract obstruction and other conditions that stimulate renal fibrogenesis induce a change in the state of differentiation. of parenchymal fibroblasts characterized by a marked increase in the secretion of several classes of collagen, and the acquisition of a contractile phenotype associated with expression of alpha-smooth muscle actin: the """"""""myofibroblast."""""""" A number of studies in the intact kidney have implicated angiontensin II, TGF- beta1, and other agents as key factors required for myofibroblast differentiation. A number of studies in the intact kidney have implicated angiotensin II, TGF-beta1, and other gents as key factors required for myofibroblast differentiation. In contrast, studies on alpha-smooth muscle actin expression in fibroblasts and other cells in culture have yielded conflicting results. Preliminary evidence presented in this application indicate that TGF-beta1 has little or not effect on the expression of mammalian fibroblast. in cultures. The focus of this project will be to identify the DNA regulatory elements and DNA-binding proteins in the alpha-smooth focus of this project will be to identify the DNA regulatory elements and DNAS-binding proteins in the alpha-smooth muscle actin promoter responsible for urinary obstruction-dependent expression in fibroblasts. Balb/c mouse fibroblasts will be marked by stable expression of green fluorescent protein (GFP), and injected into the kidneys of syngeneic mice, where they be assessed for obstruction-dependent induction of alpha- smooth muscle actin (SMA) expression. The marked fibroblasts will then be stably transfected with SMA promoter-reporter constructs using the firefly and Renilla luciferase dual reporter systems to allow identification of DNA elements essential for obstruction-dependent expression. Mobility shift assays and other techniques will then be used to identify the DNA-binding proteins interacting with these sites. Finally, the syngeneic fibroblast system will be used to express polyhistidine-tagged proteins in the interstitium of obstructed and contralateral kidneys, to identify the determinants of extracellular matrix accumulation. These studies will attempt to identify factors essential for the initiation of tubulointerstitial fibrosis in urinary tract obstruction. The results may lead to the identification of new therapeutic targets for arresting and reversing interstitial fibrosis.

Project Start
1999-03-01
Project End
1999-12-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
34
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Barnes-Jewish Hospital
Department
Type
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63110
Slatopolsky, Eduardo (2011) The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder. Kidney Int Suppl :S3-8
Morrissey, Jeremiah; Hruska, Keith; Guo, Guangjie et al. (2002) Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13 Suppl 1:S14-21
Hruska, Keith A (2002) Treatment of chronic tubulointerstitial disease: a new concept. Kidney Int 61:1911-22
Morrissey, Jeremiah; Guo, Guangjie; Moridaira, Kazuaki et al. (2002) Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. J Am Soc Nephrol 13:1499-508
Hruska, K A; Guo, G; Wozniak, M et al. (2000) Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 279:F130-43
Klahr, S (1999) Mechanisms of progression of chronic renal damage. J Nephrol 12 Suppl 2:S53-62
Hemken, P; Guo, X L; Wang, Z Q et al. (1992) Immunologic evidence that vacuolar H+ ATPases with heterogeneous forms of Mr = 31,000 subunit have different membrane distributions in mammalian kidney. J Biol Chem 267:9948-57
Reyes, A A; Robertson, G; Jenden, D J et al. (1992) Subdiaphragmatic vagotomy in rats induces systemic hypertension and sodium retention. Miner Electrolyte Metab 18:375-81
Portilla, D; Mordhorst, M; Bertrand, W et al. (1988) Protein kinase C modulates phospholipase C and increases arachidonic acid release in bradykinin stimulated MDCK cells. Biochem Biophys Res Commun 153:454-62